Mitchell et al., 1998 - Google Patents
Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIVMitchell et al., 1998
- Document ID
- 2174548103414429726
- Author
- Mitchell W
- Ding L
- Gabriel J
- Publication year
- Publication venue
- Aids
External Links
Snippet
Background: The primary antigenic domain responsible for complement-mediated antibody- dependent enhancement (C'-ADE) of HIV and simian immunodeficiency virus resides in the principal immunodominant sequence of the transmembrane protein. Objective: To identify …
- 241000580858 Simian-Human immunodeficiency virus 0 title abstract description 32
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI221846B (en) | HIV envelope polypeptides and vaccine | |
| AU732809B2 (en) | Compositions and methods for treating viral infections | |
| CA2169764C (en) | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies | |
| US20100041875A1 (en) | Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric coplexes, and uses thereof | |
| US6544752B1 (en) | Anigenically-marked non-infectious retrovirus-like particles | |
| US8715686B2 (en) | Conformationally stabilized HIV envelope immunogens | |
| Yang et al. | Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1 | |
| US9266928B2 (en) | Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction | |
| IL102092A (en) | Use of recombinant hiv envelope protein in medicament for treating hiv and therapeutic composition containing the agglomerated protein | |
| US6121021A (en) | Constitutive expression of non-infectious HIV-like particles | |
| WO2023020623A1 (en) | Fusion protein and spike protein nanoparticle for preventing or treating coronavirus infections, and use thereof | |
| Mitchell et al. | Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV | |
| AU3889600A (en) | A novel chimeric protein for prevention and treatment of hiv infection | |
| EP2430045B1 (en) | Carbohydrate binding module and use thereof | |
| AU2006200454A1 (en) | Compositions and methods for treating viral infections | |
| Robertson | Role of Antibodies Specific for the V3 Region of gp120 in HIV-1 Infection. | |
| AU2004201321A1 (en) | Compositions and methods for treating viral infections | |
| WO2010041942A1 (en) | Improved env peptides and proteins | |
| AU2004208648A1 (en) | Compositions and methods for treating infections | |
| HK1023371B (en) | Compositions and methods for treating viral infections | |
| HRP921484A2 (en) | Vaccine and treatment method of human immunodeficiency virus infection |